S
EWTX icon

SignatureFD’s Edgewise Therapeutics EWTX Stock Holding History

SignatureFD’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
363
– – ﹤0.01% 2482
2026
Q1 		$11.4K Hold
363
– – ﹤0.01% 2454
2025
Q4 		$9.01K Hold
363
– – ﹤0.01% 2475
2025
Q3 		$5.89K Hold
363
– – ﹤0.01% 2607
2025
Q2 		$4.76K Sell
363
-129
-26% -$1.86K ﹤0.01% 2624
2025
Q1 		$10.8K Buy
492
+26
+6% +$682 ﹤0.01% 2322
2024
Q4 		$12.4K Sell
466
-71
-13% -$2.26K ﹤0.01% 2289
2024
Q3 		$14.3K Buy
537
+82
+18% +$1.63K ﹤0.01% 2199
2024
Q2 		$8.2K Buy
455
+21
+5% +$366 ﹤0.01% 2355
2024
Q1 		$7.92K Hold
434
– – ﹤0.01% 2388
2023
Q4 		$4.75K Buy
434
+288
+197% +$2.02K ﹤0.01% 2513
2023
Q3 		$837 Sell
146
-211
-59% -$1.43K ﹤0.01% 2956
2023
Q2 		$2.77K Buy
357
+234
+190% +$1.97K ﹤0.01% 2705
2023
Q1 		$820 Sell
123
-163
-57% -$1.51K ﹤0.01% 3026
2022
Q4 		$2.56K Buy
286
+75
+36% +$703 ﹤0.01% 2725
2022
Q3 		$2K Buy
+211
New +$2.13K ﹤0.01% 2767

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SignatureFD's EWTX Position: Q2 2026 in Review

SignatureFD held its Edgewise Therapeutics (EWTX) position steady in Q2 2026 at 363 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.

SignatureFD first reported a position in EWTX in Q3 2022 and has held it in 16 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • SignatureFD held 363 shares of Edgewise Therapeutics worth $14.7K as of Q2 2026.
  • SignatureFD left its Edgewise Therapeutics share count unchanged in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2482 holding.
  • SignatureFD first reported a position in Edgewise Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.